Bottom line
SBHIX vs IBBQ: the short answer
SBHIX (Health & Biotechnology Portfolio) and IBBQ (Invesco Nasdaq Biotechnology ETF) are both mutual funds.
But IBBQ is far broader, holding 261 positions to 29 for SBHIX, so beyond the top names it adds exposure SBHIX doesn't have.
IBBQ is cheaper at 0.19% vs 2.6% — a difference of $241 a year per $10,000 invested.
Over one year, SBHIX returned +0.7% vs −0.6% for IBBQ.
Updated Nov 19, 2026
SBHIX vs IBBQ side by side
| SBHIX | IBBQ | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Saratoga Advantage | Invesco |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 2.6% | 0.19% |
| Annual cost per $10k | $260 | $19 |
| 10-yr cost on $10k (prospectus) | $2,934 | $242 |
| Max front load | 0% | None |
| 12b-1 fee | — | — |
| 1-yr return | +0.7% | −0.6% |
| 5-yr return (annualized) | +4.7% | — |
| 10-yr return (annualized) | +5.2% | — |
| Best quarter | +15.0% | +12.0% |
| Worst quarter | −13.0% | −11.7% |
| Net assets (fund) | $10.5M | $67.4M |
| Number of holdings | 29 | 261 |
| Portfolio turnover | 22% | 17% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SBHIX | IBBQ | Difference |
|---|---|---|---|
| 2024 | +0.7% | −0.6% | +1.3% |
| 2023 | +0.0% | +4.5% | −4.5% |
| 2022 | +2.4% | −10.2% | +12.7% |
Source: Fund prospectus bar charts
Holdings overlap
8 of SBHIX's top 25 holdings also appear in IBBQ's top 25.
| Holding | SBHIX | IBBQ |
|---|---|---|
| Jazz Pharmaceuticals Plc | 6.19% | 1.16% |
| United Therapeutics Corp | 6.17% | 1.94% |
| Amgen Inc | 5.04% | 7.10% |
| Exelixis Inc | 4.55% | 1.04% |
| Gilead Sciences Inc | 3.94% | 7.39% |
| Regeneron Pharmaceuticals Inc | 3.93% | 5.08% |
| Vertex Pharmaceuticals Inc | 3.36% | 7.38% |
| Incyte Corp | 2.89% | 1.53% |
Source: SEC Form N-PORT
SBHIX top 10
- Cardinal Health Inc — 6.44%
- Jazz Pharmaceuticals Plc — 6.19%
- United Therapeutics Corp — 6.17%
- Amgen Inc — 5.04%
- Mckesson Corp — 4.90%
- Lantheus Holdings Inc — 4.64%
- Exelixis Inc — 4.55%
- Novartis Ag — 4.50%
- Cencora Inc — 4.33%
- Gilead Sciences Inc — 3.94%
IBBQ top 10
- Invesco Private Prime Fund — 14.20%
- Gilead Sciences, Inc. — 7.39%
- Vertex Pharmaceuticals Inc. — 7.38%
- Amgen Inc. — 7.10%
- Invesco Private Government Fund — 5.48%
- Regeneron Pharmaceuticals, Inc. — 5.08%
- Alnylam Pharmaceuticals, Inc. — 3.19%
- Revolution Medicines, Inc. — 2.48%
- Biogen Inc. — 2.29%
- Illumina, Inc. — 1.98%
FAQ
What is the difference between SBHIX and IBBQ?
Which is cheaper, SBHIX or IBBQ?
Should I own both SBHIX and IBBQ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.